| CDK4/6 inhibition triggers anti-tumour immunity S Goel, MJ DeCristo, AC Watt, H BrinJones, J Sceneay, BB Li, N Khan, ... Nature 548 (7668), 471-475, 2017 | 1179 | 2017 |
| The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis SS McAllister, RA Weinberg Nature cell biology 16 (8), 717-727, 2014 | 947 | 2014 |
| Breast cancer as a systemic disease: a view of metastasis AJ Redig, SS McAllister Journal of internal medicine 274 (2), 113-126, 2013 | 766 | 2013 |
| Systemic endocrine instigation of indolent tumor growth requires osteopontin SS McAllister, AM Gifford, AL Greiner, SP Kelleher, MP Saelzler, TA Ince, ... Cell 133 (6), 994-1005, 2008 | 490 | 2008 |
| Growth-inhibitory and tumor-suppressive functions of p53 depend on its repression of CD44 expression S Godar, TA Ince, GW Bell, D Feldser, JL Donaher, J Bergh, A Liu, K Miu, ... Cell 134 (1), 62-73, 2008 | 487 | 2008 |
| CDK4/6 inhibition in cancer: beyond cell cycle arrest S Goel, MJ DeCristo, SS McAllister, JJ Zhao Trends in cell biology 28 (11), 911-925, 2018 | 377 | 2018 |
| Tumor-host interactions: a far-reaching relationship SS McAllister, RA Weinberg Journal of clinical oncology 28 (26), 4022-4028, 2010 | 344 | 2010 |
| Fibroblasts as architects of cancer pathogenesis T Marsh, K Pietras, SS McAllister Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1832 (7 …, 2013 | 304 | 2013 |
| Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice M Elkabets, AM Gifford, C Scheel, B Nilsson, F Reinhardt, MA Bray, ... The Journal of clinical investigation 121 (2), 784-799, 2011 | 255 | 2011 |
| Identification of luminal breast cancers that establish a tumor-supportive macroenvironment defined by proangiogenic platelets and bone marrow–derived cells HS Kuznetsov, T Marsh, BA Markens, Z Castaño, A Greene-Colozzi, ... Cancer discovery 2 (12), 1150-1165, 2012 | 169 | 2012 |
| p38MAPK plays a crucial role in stromal-mediated tumorigenesis E Alspach, KC Flanagan, X Luo, MK Ruhland, H Huang, E Pazolli, ... Cancer discovery 4 (6), 716-729, 2014 | 155 | 2014 |
| IL-1β inflammatory response driven by primary breast cancer prevents metastasis-initiating cell colonization Z Castano, BP San Juan, A Spiegel, A Pant, MJ DeCristo, T Laszewski, ... Nature cell biology 20 (9), 1084-1097, 2018 | 146 | 2018 |
| Subclonal cooperation drives metastasis by modulating local and systemic immune microenvironments M Janiszewska, DP Tabassum, Z Castaño, S Cristea, KN Yamamoto, ... Nature cell biology 21 (7), 879-888, 2019 | 132 | 2019 |
| Aspirin suppresses growth in PI3K-mutant breast cancer by activating AMPK and inhibiting mTORC1 signaling WS Henry, T Laszewski, T Tsang, F Beca, AH Beck, SS McAllister, ... Cancer research 77 (3), 790-801, 2017 | 110 | 2017 |
| Interferon signaling is diminished with age and is associated with immune checkpoint blockade efficacy in triple-negative breast cancer J Sceneay, GJ Goreczny, K Wilson, S Morrow, MJ DeCristo, ... Cancer Discovery 9 (9), 1208-1227, 2019 | 104 | 2019 |
| The immunology of hormone receptor positive breast cancer J Goldberg, RG Pastorello, T Vallius, J Davis, YX Cui, J Agudo, AG Waks, ... Frontiers in immunology 12, 674192, 2021 | 89 | 2021 |
| The tumor macroenvironment and systemic regulation of breast cancer progression Z Castaño, K Tracy, SS McAllister The International journal of developmental biology 55 (7-8-9), 889-897, 2011 | 82 | 2011 |
| Inhibition of epithelial cell migration and Src/FAK signaling by SIRT3 JJ Lee, RAH van De Ven, E Zaganjor, MR Ng, A Barakat, JJPG Demmers, ... Proceedings of the National Academy of Sciences 115 (27), 7057-7062, 2018 | 64 | 2018 |
| Loss of RasGAP tumor suppressors underlies the aggressive nature of luminal B breast cancers SN Olsen, A Wronski, Z Castaño, B Dake, C Malone, T De Raedt, M Enos, ... Cancer discovery 7 (2), 202-217, 2017 | 60 | 2017 |
| The bed and the bugs: interactions between the tumor microenvironment and cancer stem cells Z Castaño, CM Fillmore, CF Kim, SS McAllister Seminars in cancer biology 22 (5-6), 462-470, 2012 | 60 | 2012 |
